APA (7th ed.) Citation

Jiaming, L., Yanfeng, Y., Yao, D., Yawei, H., Linlin, B., Baoying, H., . . . Wenjie, T. (2017). The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Vaccine, 35(1), 10-18. https://doi.org/10.1016/j.vaccine.2016.11.064

Chicago Style (17th ed.) Citation

Jiaming, Lan, et al. "The Recombinant N-terminal Domain of Spike Proteins Is a Potential Vaccine Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection." Vaccine 35, no. 1 (2017): 10-18. https://doi.org/10.1016/j.vaccine.2016.11.064.

MLA (9th ed.) Citation

Jiaming, Lan, et al. "The Recombinant N-terminal Domain of Spike Proteins Is a Potential Vaccine Against Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection." Vaccine, vol. 35, no. 1, 2017, pp. 10-18, https://doi.org/10.1016/j.vaccine.2016.11.064.